Bioanalysis Zone

Biomarker measurements: how far have we come and where are we heading?


Biomarker research has attracted the attention of scientists, clinicians, academicians, regulators and many others for at least two decades now, due to the compelling promise and the immense potential for use of biomarkers as diagnostic, prognostic and theranostic tools at the patient level and their use in drug development. While there have been sporadic successes, the translation of research into biomarkers that can be applied in the clinic is unrealized to a large extent, even today. In this editorial, the author shares a few thoughts and perspectives on the challenges related to measurement of biomarkers and where the field is heading.

To view restricted content, please:

Leave A Comment